News Related to Postoperative Pain

Related coverage linked through entity extraction aliases.

Health Canada Accepts Vertex's Suzetrigine New Drug Submission for Acute Pain

Aug 30, 2026

Health Canada accepted Vertex's New Drug Submission for suzetrigine, a selective NaV1.8 pain signal inhibitor for acute pain. The FDA-approved drug could become Canada's first new class of acute pain medicine in over 20 years.

Postoperative Pain Advances: Lidocaine Patch Trial, Liposomal Bupivacaine Protocol, and Pipeline Report

Jul 18, 2026

Lidocaine patches cut opioid use after radiofrequency ablation for hepatocellular carcinoma; a protocol tests liposomal bupivacaine for mastectomy; a pipeline report profiles 40+ companies.